Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(7%)
Results Posted
18%(2 trials)

Phase Distribution

Ph phase_2
1
7%
Ph phase_3
1
7%
Ph phase_1
11
79%

Phase Distribution

11

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
11(84.6%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
unknown1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 111 (84.6%)
Phase 21 (7.7%)
Phase 31 (7.7%)

Trials by Status

unknown17%
active_not_recruiting17%
completed1179%
withdrawn17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT04303780Phase 3

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Completed
NCT05118854Phase 2

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

Active Not Recruiting
NCT04380753Phase 1

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Completed
NCT04667234

Expanded Access of Sotorasib

Unknown
NCT05598281Phase 1

Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants

Completed
NCT05581992Phase 1

Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05577624Phase 1

A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants

Completed
NCT05581758Phase 1

A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05550129Phase 1

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

Completed
NCT05568082Phase 1

A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05599828Phase 1

A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05180422Phase 1

A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis

Withdrawn
NCT05578859Phase 1

A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects

Completed
NCT05571163Phase 1

A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14